001     309977
005     20260220160115.0
024 7 _ |a 10.1038/s44318-026-00712-4
|2 doi
024 7 _ |a pmid:41714729
|2 pmid
024 7 _ |a 0261-4189
|2 ISSN
024 7 _ |a 1460-2075
|2 ISSN
037 _ _ |a DKFZ-2026-00403
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Weiden, Eva-Maria
|0 0000-0001-9582-4448
|b 0
245 _ _ |a TRPML1 suppresses pulmonary fibrosis by limiting collagen and elastin deposition.
260 _ _ |a [London]
|c 2026
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1771599663_3240620
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
520 _ _ |a In pulmonary fibrosis lung tissue is thickened and scarred, and the lungs become progressively stiffer and smaller, leading to low levels of blood oxygen and shortness of breath. Lung fibrosis is not curable and life expectancy is reduced. Fibrosis is characterized by an increased accumulation of extracellular matrix (ECM) proteins such as collagen and elastin. ECM proteins are degraded predominantly by matrix metalloproteinases (MMPs). Here, we show that the lysosomal cation channel TRPML1, which causes the lysosomal storage disorder mucolipidosis type IV (MLIV) when mutated or lost, regulates the levels of MMPs in the ECM of mouse airways, modulating exocytosis of MMP2, 8, 9, 12, and 19, which mediate collagen/elastin degradation. While TRPML1 loss reduces MMP levels in lung macrophage and fibroblast supernatants, small molecule activation of TRPML1 results in increased levels. MLIV mice display a fibrosis-like lung phenotype similar to the phenotype evoked by bleomycin. We thus identify TRPML1 as a regulator of MMP release in the lung with loss of TRPML1 resulting in lung fibrosis due to excessive extracellular collagen and elastin accumulation.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Mcoln1
|2 Other
650 _ 7 |a Pulmonary Fibrosis
|2 Other
650 _ 7 |a TRPML
|2 Other
650 _ 7 |a TRPML1
|2 Other
650 _ 7 |a TRPML3
|2 Other
700 1 _ |a Serianz, Zala
|0 0009-0009-5753-3637
|b 1
700 1 _ |a Klingl, Yvonne
|0 0000-0003-2779-3357
|b 2
700 1 _ |a Jörs, Simone
|b 3
700 1 _ |a Jaślan, Dawid
|0 0000-0002-0685-7633
|b 4
700 1 _ |a Keller, Marco
|0 0000-0003-4792-3980
|b 5
700 1 _ |a Castro, Sandra Prat
|b 6
700 1 _ |a Mkhitaryan, Mane
|0 0009-0008-7426-3088
|b 7
700 1 _ |a Jeridi, Aicha
|b 8
700 1 _ |a Briukhovetska, Daria
|0 0000-0002-2073-2335
|b 9
700 1 _ |a Spix, Barbara
|b 10
700 1 _ |a Scotto Rosato, Anna
|b 11
700 1 _ |a Agami, Ahmed
|b 12
700 1 _ |a Schiller, Herbert B
|b 13
700 1 _ |a Rajan, Suhasini
|b 14
700 1 _ |a Schredelseker, Johann
|0 0000-0002-6657-0466
|b 15
700 1 _ |a Fois, Giorgio
|0 0000-0001-5414-1149
|b 16
700 1 _ |a Frick, Manfred
|b 17
700 1 _ |a Kobold, Sebastian
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Klein, Margarethe
|0 0000-0002-3919-8427
|b 19
700 1 _ |a Geisler, Fabian
|b 20
700 1 _ |a Garcia-Fortanet, Jorge
|0 0009-0006-9232-2198
|b 21
700 1 _ |a Murphy, Leon O
|b 22
700 1 _ |a Bracher, Franz
|0 0000-0003-0009-8629
|b 23
700 1 _ |a Wahl-Schott, Christian
|b 24
700 1 _ |a Gudermann, Thomas
|0 0000-0002-0323-7965
|b 25
700 1 _ |a Dietrich, Alexander
|0 0000-0002-1168-8707
|b 26
700 1 _ |a Biel, Martin
|0 0000-0002-9974-3052
|b 27
700 1 _ |a Yildirim, Ali Önder
|0 0000-0003-1969-480X
|b 28
700 1 _ |a Grimm, Christian
|0 0000-0002-0177-5559
|b 29
773 _ _ |a 10.1038/s44318-026-00712-4
|0 PERI:(DE-600)1467419-1
|p nn
|t The EMBO journal
|v nn
|y 2026
|x 0261-4189
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2026
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-30
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-08T07:44:01Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-08T07:44:01Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review, Double anonymous peer review
|d 2024-04-08T07:44:01Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2024-04-08T07:44:01Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EMBO J : 2022
|d 2024-12-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-30
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-30
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b EMBO J : 2022
|d 2024-12-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-30
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21